A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers

The safety and maximum tolerated dose (MTD) of erlotinib with docetaxel/carboplatin were assessed in patients with ovarian cancer. Chemonaive patients received intravenous docetaxel (75 mg m(−2)) and carboplatin (area under the curve 5) on day 1 of a 3-week cycle, and oral erlotinib at 50 (cohort 1)...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Vasey, P A, Gore, M, Wilson, R, Rustin, G, Gabra, H, Guastalla, J-P, Lauraine, E P, Paul, J, Carty, K, Kaye, S
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2008
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2410113/
https://ncbi.nlm.nih.gov/pubmed/18506181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604371
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker